SRC-3, a coactivator of AR that is often upregulated in prostate cancer (Zhou et al., 2005), is another SPOP ubiquitination target (Geng et al., 2013; Li et al., 2011). The gene discussed is NCOA3; the disease is prostate carcinoma.